These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33648830)

  • 1. Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
    Pontone GM; Mills KA
    Am J Geriatr Psychiatry; 2021 Jun; 29(6):530-540. PubMed ID: 33648830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease.
    Egan SJ; Laidlaw K; Starkstein S
    J Parkinsons Dis; 2015; 5(3):443-51. PubMed ID: 26406124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
    Troeung L; Egan SJ; Gasson N
    PLoS One; 2013; 8(11):e79510. PubMed ID: 24236141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial interventions for depression and anxiety in Parkinson's disease.
    Yang S; Sajatovic M; Walter BL
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Nonmotor Symptoms in Parkinson's Disease.
    Sauerbier A; Cova I; Rosa-Grilo M; Taddei RN; Mischley LK; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():361-379. PubMed ID: 28554415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-Behavioral Therapy for Anxiety in Parkinson's Disease.
    Reynolds GO; Saint-Hilaire M; Thomas CA; Barlow DH; Cronin-Golomb A
    Behav Modif; 2020 Jul; 44(4):552-579. PubMed ID: 30931594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms in Parkinson's Disease.
    Aarsland D; Kramberger MG
    J Parkinsons Dis; 2015; 5(3):659-67. PubMed ID: 26406147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Growing Role of Cognitive Behavior Therapy in the Treatment of Parkinson's Disease.
    Lopes SR; Khan S; Chand S
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):310-320. PubMed ID: 34219525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms in Parkinson's disease.
    Lemke MR
    Eur J Neurol; 2008 Apr; 15 Suppl 1():21-5. PubMed ID: 18353133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: A systematic review and meta-analysis.
    Zhang Q; Yang X; Song H; Jin Y
    Complement Ther Clin Pract; 2020 May; 39():101111. PubMed ID: 32379650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management.
    Stocchi F; Angelo Antonini ; Barone P; Bellelli G; Fagiolini A; Ferini Strambi L; Sorbi S; Padovani A
    Neurol Sci; 2023 Sep; 44(9):3123-3131. PubMed ID: 37100925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric symptoms in Parkinson's disease.
    Schneider F; Althaus A; Backes V; Dodel R
    Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():55-9. PubMed ID: 18985296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing depression and anxiety symptoms in patients with Parkinson's disease: The effectiveness of group cognitive behavioral therapy.
    Rezazadeh Yazd SA; Gashtil S; Moradpoor M; Pishdar S; Nabian P; Kazemi Z; Naeim M
    Parkinsonism Relat Disord; 2023 Jul; 112():105456. PubMed ID: 37244105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in Parkinson's disease.
    Burn DJ
    Eur J Neurol; 2002 Nov; 9 Suppl 3():44-54. PubMed ID: 12464121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
    Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE
    Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote delivery of psychological interventions for Parkinson's disease.
    Swalwell C; Pachana NA; Dissanayaka NN
    Int Psychogeriatr; 2018 Dec; 30(12):1783-1795. PubMed ID: 29747712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-motor symptoms of Parkinson disease and their management].
    Sahli H; Seddik L; Rémy P
    Rev Prat; 2018 May; 68(5):508-512. PubMed ID: 30869414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.
    Armento ME; Stanley MA; Marsh L; Kunik ME; York MK; Bush AL; Calleo JS
    J Parkinsons Dis; 2012; 2(2):135-51. PubMed ID: 23939438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.